delisting

Smart Share Global completes going-private merger at $1.25 per ADS, ending Nasdaq listing as Chinese charging services company transitions to private ownership.

Smart Share Global completed going-private merger, delisting from Nasdaq. ADS holders receive $1.25 per share in cash; other shareholders get $0.625.

Blue Owl Capital to acquire Sila Realty Trust for $2.4 billion at $30.38 per share, a 19% premium. Deal expected to close Q2-Q3 2026 pending shareholder approval.

Keurig Dr Pepper completes JDE Peet's acquisition with 97.75% share acceptance, creating global coffee giant with Rafael Oliveira as CEO.

Actelis Networks crashed 73% after Nasdaq delisting notice due to minimum bid price noncompliance, with stock down 99% yearly.

Hologic completes $18.3B private equity acquisition by Blackstone and TPG, with shareholders receiving $76 per share plus conditional payments.

Keurig Dr Pepper's Kodiak BidCo completes JDE Peet's tender offer with 96.22% acceptance, declaring offer unconditional ahead of April 2026 settlement.

Zynex filed for Chapter 11 bankruptcy after losing Tricare payments and settling federal fraud allegations for $85M, triggering securities class action and near-total equity loss.

Zynex faces securities class action lawsuit following bankruptcy, $85M fraud settlement, and delisting after alleged systematic overbilling scheme.

Medical device company $ZYXI files Chapter 11 after Tricare suspension, fraud indictments of executives, and systematic overbilling scheme. Class action filed.

Zynex files for bankruptcy after fraud settlement; class action lawsuit filed against medical device maker over alleged oversupply scheme. Lead plaintiff deadline: April 21, 2026.

Zynex faces securities lawsuit alleging systematic overbilling fraud. CEO indicted, Tricare suspended $85M payments, company filed bankruptcy and lost Nasdaq listing.

1567208 B.C. Ltd. completed acquisition of Quipt Home Medical for US$3.65/share (US$162.3M) via court-approved arrangement; shares delisted from TSX and NASDAQ.

Securities lawsuit filed against Zynex following bankruptcy, delisting, and $85M fraud settlement. Executives indicted for healthcare fraud.

Nasdaq Stockholm approves CoinShares' delisting, with trading to cease March 20, 2026 and effective delisting March 31, 2026. Company relocating to Nasdaq Stock Market.

Nasdaq Stockholm approves CoinShares delisting application pending court approval. Last trading day March 20, 2026; firm plans U.S. Nasdaq relisting.

Nasdaq Stockholm approves CoinShares' delisting application as part of merger with Vine Hill Capital. U.S. relisting expected by March 2026.

CoinShares approved for delisting from Nasdaq Stockholm and merging with SPACs for relisting on US Nasdaq, with final delisting March 31, 2026.

Lisata Therapeutics agreed to be acquired by Kuva Labs for $5.00 per share plus up to $1.00 contingent payment, closing expected in Q2 2026.

Quipt Home Medical gains final court approval for US$3.65/share acquisition by Kingswood and Forager Capital affiliates, with delisting expected by March 2026.